PRTG

Alpha Compute Corp. (PRTG) | Rumor.io

Alpha Compute

PRTG

Attention (50-day avg)0%

Attention rank (50-day avg)#4,694

Bullish sentiment (50-day avg)100%

Price to earnings ratio0.19

Market capitalization12.7M

Earnings per share-5.72

Dividend yield (TTM)4.66%

Revenue (annual)0

Net income (annual)-6.8M

Social

What share of all stock conversation is about PRTG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 3

Portage Biotech Inc. ($PRTG) has rebranded to AlphaTON Capital with a new ticker $ATON to launch a $100M TON Digital Asset Treasury Strategy.
The company's CEO, Brittany Kaiser, is leading the effort to create a decentralized economy with Telegram's 1B-user ecosystem, focusing on user empowerment and data sovereignty.
AlphaTON Capital's shares ($ATON, previously $PRTG) are trading higher after announcing a financing to acquire ~$100 million TON tokens and establish a specialized digital asset treasury company.

Generated by AI

Sentiment

Of the messages about PRTG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.49% +11.38
Bearish	—	—	—	3.51% -11.38

Jun 25

Portage Biotech Inc. ($PRTG) has regained Nasdaq compliance, potentially boosting market confidence and eliminating delisting concerns.
The company has secured a deal involving diabetic ulcer technology and acquired a 27% stake, which could support future growth and potentially lead to a 21-32% increase in value.
$PRTG is showing strong momentum, with a 57% premarket gain and a solid push towards $6.80, with the potential for further growth if $6.79 breaks with volume.

Generated by AI

Topics

Of the messages about PRTG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	89.29%
Analysts	—	—	0%	0%
Controversies	—	—	0%	2.38%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	8.33%

Announcements· Jun 25

Portage Biotech Inc. ($PRTG) has cleared all Nasdaq listing requirements, confirming its market position and avoiding delisting.
The company has regained full compliance with Nasdaq continued listing requirements, resolving the delisting threat.
Portage Biotech has announced significant advancements in its pipeline, including the compedica deal bringing diabetic ulcer tech and a 27% stake, as well as positive results in mesothelioma models for PORT-7.

Technical Analysis· Mar 28

$PRTG is forming a falling wedge and needs to hold support at a certain level.
The stock has broken a bull descending wedge and is now in a new uptrend, with a bullish pennant forming.
$PRTG has a monster resistance at $13.00 on the daily chart, and traders should be cautious and secure profits.

Generated by AI

Community

Of the messages about PRTG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	40.77%
Newcomers	—	—	100%	59.23%

Regulars· Jun 25

Portage Biotech Inc. has cleared all Nasdaq listing requirements, confirming its market position and regaining full compliance with Nasdaq continued listing requirements.
The company's stock has shown significant gains, with a +17.5% pre-market price increase and a +21.7% pre-market price increase, following the announcement of its compliance.
The stock's 700k float is mentioned as a factor that could support a dip to 6.40, with the regulars noting the tight stop and the potential for a move back over 7.

Newcomers· Jun 25

Newcomers are excited about the potential for a biotech uptrend, with $PRTG reaching a weekly high of $5.380 (+1.70%).
The Nasdaq compliance issue has been resolved, removing the threat of delisting and bringing a sense of stability to the company.
The company's recent deal with Compedica, including the acquisition of diabetic ulcer tech and a 27% stake, is seen as a positive catalyst for future growth.

Generated by AI

News

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025...

1mo agoBarchart.com

Portage Biotech and Compedica Stock-for-Stock Exchange

Portage Biotech and Compedica Stock-for-Stock Exchange...

1mo agoBarchart.com

Also Discussed

Investors talking about PRTG also mention

#	Name	Attention
1	Biohaven Ltd.BHVN	0%-0.01
2	Vision Marine Technologies Inc.VMAR	0%new
3	MiNK Therapeutics, Inc.INKT	0%new
4	Tenon Medical, Inc.TNON	0%new
5	AGE - AgeX Therapeutics, Inc.	——
6	KWE - KWESST Micro Systems Inc.	——
7	Cognition Therapeutics, Inc.CGTX	0%+0
8	LPTV - Loop Media, Inc.	——
9	Above Food Ingredients Inc.ABVE	0%new
10	OMIC - Singular Genomics Systems, Inc.	——

Alpha Compute Corp.

Financial Services
Asset Management

Alpha Compute Corp. is a provider of AI Confidential Compute and GPU-as-a-Service (GPUaaS) solutions. The company owns and operates AI infrastructure powered by confidential compute technologies and hardware-level encryption, enabling privacy-preserving computation for various applications. Its GPU assets, including Nvidia B300 units integrated with Dell systems, support high-performance computing needs in data centers. Alpha Compute Corp. delivers these services to prominent partners such as Telegram, Animoca Brands, and Midnight Network, facilitating secure AI workloads across industries. The company focuses on scaling its infrastructure through strategic data center expansions, such as build-outs with Equinex and AtNorth in Sweden, to meet growing demand for confidential cloud architecture and enterprise GPU services. Founded in Road Town, Tortola, British Virgin Islands, Alpha Compute Corp. plays a key role in the AI compute market by offering scalable, secure alternatives to traditional cloud computing.

Website

Location

8 The Green

Dover, DE, 19901

United States

Social

What share of all stock conversation is about PRTG?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% 0

Sep 3

Portage Biotech Inc. ($PRTG) has rebranded to AlphaTON Capital with a new ticker $ATON to launch a $100M TON Digital Asset Treasury Strategy.
The company's CEO, Brittany Kaiser, is leading the effort to create a decentralized economy with Telegram's 1B-user ecosystem, focusing on user empowerment and data sovereignty.
AlphaTON Capital's shares ($ATON, previously $PRTG) are trading higher after announcing a financing to acquire ~$100 million TON tokens and establish a specialized digital asset treasury company.

Generated by AI

Sentiment

Of the messages about PRTG that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	96.49% +11.38
Bearish	—	—	—	3.51% -11.38

Jun 25

Portage Biotech Inc. ($PRTG) has regained Nasdaq compliance, potentially boosting market confidence and eliminating delisting concerns.
The company has secured a deal involving diabetic ulcer technology and acquired a 27% stake, which could support future growth and potentially lead to a 21-32% increase in value.
$PRTG is showing strong momentum, with a 57% premarket gain and a solid push towards $6.80, with the potential for further growth if $6.79 breaks with volume.

Generated by AI

Topics

Of the messages about PRTG that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	89.29%
Analysts	—	—	0%	0%
Controversies	—	—	0%	2.38%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	8.33%

Announcements· Jun 25

Portage Biotech Inc. ($PRTG) has cleared all Nasdaq listing requirements, confirming its market position and avoiding delisting.
The company has regained full compliance with Nasdaq continued listing requirements, resolving the delisting threat.
Portage Biotech has announced significant advancements in its pipeline, including the compedica deal bringing diabetic ulcer tech and a 27% stake, as well as positive results in mesothelioma models for PORT-7.

Technical Analysis· Mar 28

$PRTG is forming a falling wedge and needs to hold support at a certain level.
The stock has broken a bull descending wedge and is now in a new uptrend, with a bullish pennant forming.
$PRTG has a monster resistance at $13.00 on the daily chart, and traders should be cautious and secure profits.

Generated by AI

Community

Of the messages about PRTG, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	40.77%
Newcomers	—	—	100%	59.23%

Regulars· Jun 25

Portage Biotech Inc. has cleared all Nasdaq listing requirements, confirming its market position and regaining full compliance with Nasdaq continued listing requirements.
The company's stock has shown significant gains, with a +17.5% pre-market price increase and a +21.7% pre-market price increase, following the announcement of its compliance.
The stock's 700k float is mentioned as a factor that could support a dip to 6.40, with the regulars noting the tight stop and the potential for a move back over 7.

Newcomers· Jun 25

Newcomers are excited about the potential for a biotech uptrend, with $PRTG reaching a weekly high of $5.380 (+1.70%).
The Nasdaq compliance issue has been resolved, removing the threat of delisting and bringing a sense of stability to the company.
The company's recent deal with Compedica, including the acquisition of diabetic ulcer tech and a 27% stake, is seen as a positive catalyst for future growth.

Generated by AI

Alpha Compute

Social

Sep 3

Jun 25

Announcements· Jun 25

Technical Analysis· Mar 28

Regulars· Jun 25

Newcomers· Jun 25

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Portage Biotech and Compedica Stock-for-Stock Exchange

Also Discussed

Alpha Compute Corp.

Company Information

Location

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

Portage Biotech and Compedica Stock-for-Stock Exchange

Also Discussed

Social

Sep 3

Jun 25

Announcements· Jun 25

Technical Analysis· Mar 28

Regulars· Jun 25

Newcomers· Jun 25